How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.

G. Tavernier (Manchester (Greater Manchester), United Kingdom), P. Aspin (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom), D. Allen (Manchester (Greater Manchester), United Kingdom), R. Niven (Manchester (Greater Manchester), United Kingdom)

Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Session: Monitoring of inflammation in remodelling
Session type: E-poster session
Number: 3315
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Tavernier (Manchester (Greater Manchester), United Kingdom), P. Aspin (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom), D. Allen (Manchester (Greater Manchester), United Kingdom), R. Niven (Manchester (Greater Manchester), United Kingdom). How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.. 3315

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002

Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Source: Eur Respir J 2006; 27: 483-494
Year: 2006



Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


The need of analysing induced sputum absolute cell counts in addition to cell percentages in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004

BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children
Source: Annual Congress 2011 - Flexible bronchoscopy in the diagnosis of paediatric lung diseases
Year: 2011

Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010


Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005

The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001

Cost-effectiveness comparison of three methods for differential cell count in induced sputum
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002

Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011


The regulation of apoptosis in the induced sputum cells of patients with bronchial asthma (BA) using different therapeutic programms
Source: Eur Respir J 2003; 22: Suppl. 45, 79s
Year: 2003

Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation?
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009

Budesoinde/formoterol: does eosinophil count cause different outcomes?
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019


Change of biochemical parameters of sputum in patients with different types of COPD exaserbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009


The effect of time elapsed since expectoration on sputum eosinophil differential cell counts
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019


Asthma treatment based on sputum cell counts or usual clinical outcomes: the LOMA study
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003

The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019




Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017